1. Available
   1. Vaccine is approved an in sufficient supply to reach the country's population.
      1. Technology portfolio and access
         1. Tech transfer and drug substance manufacturing
            1. Upstream/downstream sourcing and manufacturing
2. Aministrable
   1. Appropriate individuals can receive vaccination at convenient locations.
      1. Population segmentation
         1. Vaccination dispensing strategy
3. Accessible
   1. Distributed and stored for use.
      1. Ordering
         1. Logistics, transport, and warehousing
4. Acceptable
   1. Consumers have accurate information they trust, and they choose to be vaccinated.
      1. Public communications, messaging and education
         1. Healthcare workforce education
5. Affordable
   1. Costs of vaccine and administration are amenable to both payers (public/government and private) and consumers.
      1. Funding
         1. Reimbursement strategy
6. Accountable
   1. Patients receive full course of treatment and monitoring is in place on post-launch outcomes.
      1. IT infrastructure and interoperability
         1. Ongoing monitoring and reporting
7. Read more at https://www.mckinsey.com/industries/public-and-social-sector/our-insights/the-covid-19-vaccines-are-here-what-comes-next#